Form4insider filings, from the source

SEC Form 4 · accession 0001477932-18-001025

PREMIER BIOMEDICAL INC · BIEI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
John C Pauly
Director
Period of report
Dec 22, 2017
Accepted (ET)
Feb 26, 2018 · 7:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001515740

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Warrant (right to buy)$0.005Dec 22, 2017A2,000,000ADec 22, 2017Dec 22, 2024Common Stock2,000,0002,000,000D